Short communication · 25 Feb 2021
Conference abstractPublished 28 Apr 2016
Cardio embolic stroke: A review
Johns Hopkins Aramco Healthcare, Saudi Arabia
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Stroke continues to have a major impact on the public health of our nation. Preventing stroke is a key to reducing its societal burden from a human and financial perspective. WHO deemed stroke as second leading cause of morbidity and mortality. Stroke (ischemic and hemorrhagic) constitutes 7% of all deaths annually in North America and Western Europe. In Saudi Arabia, accurate estimate is lacking, however, based on an older provincial population-based survey, the estimate is 30/100,000 and about one every 6 minutes. Stroke prevention is being transformed from a personal style or belief into evidence-based medicine. Ischemic stroke constitute about 70-80% of all strokes and is not a single disease; it is a system of diverse etiologies and pathogenic mechanisms. Although epidemiological realities are distressing, major advances in secondary stroke prevention and to a lesser extent, in primary prevention, has been elucidated. Despite the fact that the largely artificial distinction of primary and secondary prevention has become elusive, with the multitude of risk factors added together in different individual poses similar risk, hence, equally aggressive non-pharmacological and pharmacological intervention. Considerable research has led to a better delineation of risk factors, as well as an expanded understanding of pathophysiological subtypes. Atherosclerosis of the brain and heart vessels plays a predominant pathological role. Large artery atherosclerosis leads to hypo perfusion or atherogenic emboli, whereas micro atheroma and lipohyalinosis of small penetrating vessels cause lacunar infarcts. Approximately 20% of ischemic strokes are due to cardio embolism, commonly due to atrial fibrillation of up to 45%. 30% are cryptogenic and less than 5% due to a variety of unusual causes. Stroke research has evolved over the past decade elaborating that; different subtypes of stroke respond differently to specific interventions for stroke prevention of which cardio embolic strokes bear a big toll.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 26 Dec 2020
Dual Versus Mono Antiplatelet Therapy for Acute Non- Cardio Embolic Ischemic Stroke or Transient Ischemic Attack
Short communication · 23 Mar 2021
Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack- Christessa Emille Que Albay - Cardinal Santos Medical Center
Conference abstract · 21 Aug 2020
Dual Versus Mono Antiplatelet Therapy for Acute Non- Cardio Embolic Ischemic Stroke or Transient Ischemic Attack, An Efficacy and Safety Analysis - Updated Meta-Analysis
Conference abstract · 2020
Neurology Congress 2020: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack- Christessa Emille Que Albay - Cardinal Santos Medical Center
More from this journal
The newest in Neurological Disorders.
Commentary · 24 Feb 2026
Vertebrobasilar Dolichoectasia: A Meta-Analysis of Clinical Manifestations and Treatment Approaches
Commentary · 24 Feb 2026
Leveraging Multi-Dimensional Encoding in Single-Channel Haptic Feedback for Enhanced Two-Dimensional Control
Commentary · 24 Feb 2026
The Paradox of Seizure Frequency Reporting: Over counted, Underreported, and Its Clinical Implications
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalNeurological Disorders
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Shireen Qureshi”

